Harry Yang

573 total citations
8 papers, 52 citations indexed

About

Harry Yang is a scholar working on Statistics and Probability, Economics and Econometrics and Statistics, Probability and Uncertainty. According to data from OpenAlex, Harry Yang has authored 8 papers receiving a total of 52 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Statistics and Probability, 2 papers in Economics and Econometrics and 2 papers in Statistics, Probability and Uncertainty. Recurrent topics in Harry Yang's work include Statistical Methods in Clinical Trials (2 papers), Advanced Statistical Process Monitoring (2 papers) and Advanced Statistical Methods and Models (1 paper). Harry Yang is often cited by papers focused on Statistical Methods in Clinical Trials (2 papers), Advanced Statistical Process Monitoring (2 papers) and Advanced Statistical Methods and Models (1 paper). Harry Yang collaborates with scholars based in United States, Belgium and Cyprus. Harry Yang's co-authors include Binbing Yu, Steven Novick, John J. Peterson, Omid Poursaeed, Ser-Nam Lim, Tianxing Jiang, Serge Belongie, Lingmin Zeng and Bruno Boulanger and has published in prestigious journals such as Pharmaceutical Statistics, Dissolution Technologies and Contemporary Clinical Trials Communications.

In The Last Decade

Harry Yang

8 papers receiving 50 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry Yang United States 4 15 12 12 12 10 8 52
Feiyu Gao China 6 3 0.2× 15 1.3× 1 0.1× 3 0.3× 16 1.6× 15 103
René Jäkel Germany 5 9 0.8× 4 0.3× 13 1.3× 15 61
Uriel Singer Israel 5 23 1.9× 8 0.7× 6 0.6× 10 59
Kshitij Mehta United States 6 11 0.9× 28 2.3× 5 0.5× 13 66
Xuan Zang China 3 20 1.7× 2 0.2× 57 4.8× 37 3.7× 10 94
David Baehrens Switzerland 3 20 1.7× 1 0.1× 10 0.8× 11 1.1× 5 42
Moonshik Shin South Korea 5 1 0.1× 13 1.1× 8 0.7× 25 2.5× 8 75
Weiyang Xie China 5 27 2.3× 40 3.3× 23 2.3× 6 77
Huichun Zhu United States 2 3 0.2× 10 0.8× 1 0.1× 7 0.7× 3 47
Fabian Immler Germany 6 26 2.2× 6 0.5× 6 0.6× 17 76

Countries citing papers authored by Harry Yang

Since Specialization
Citations

This map shows the geographic impact of Harry Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Yang more than expected).

Fields of papers citing papers by Harry Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Yang. The network helps show where Harry Yang may publish in the future.

Co-authorship network of co-authors of Harry Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Yang. A scholar is included among the top collaborators of Harry Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Yang. Harry Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Yang, Harry. (2022). Data Science, AI, and Machine Learning in Drug Development. 1 indexed citations
2.
Yang, Harry & Binbing Yu. (2021). Real-World Evidence in Drug Development and Evaluation. 3 indexed citations
3.
Poursaeed, Omid, Tianxing Jiang, Harry Yang, Serge Belongie, & Ser-Nam Lim. (2021). Robustness and Generalization via Generative Adversarial Training. 2021 IEEE/CVF International Conference on Computer Vision (ICCV). 15691–15700. 12 indexed citations
4.
Yu, Binbing, et al.. (2019). A note on the determination of non-inferiority margins with application in oncology clinical trials. Contemporary Clinical Trials Communications. 16. 100454–100454. 2 indexed citations
5.
Zeng, Lingmin, et al.. (2019). Comparisons of outlier tests for potency bioassays. Pharmaceutical Statistics. 19(3). 230–242. 5 indexed citations
6.
Zeng, Lingmin, et al.. (2018). Effect of a statistical outlier in potency bioassays. Pharmaceutical Statistics. 17(6). 701–709. 3 indexed citations
7.
Novick, Steven, et al.. (2016). In Vitro Dissolution Curve Comparisons: A Critique of Current Practice. Dissolution Technologies. 23(1). 14–23. 17 indexed citations
8.
Yang, Harry. (2016). Analytical Method Validation. 45–72. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026